Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: data from two Italian COVID-19 units
Abstract The coronavirus 2019 disease (COVID-19) is characterised by a heterogeneous clinical presentation, a complex pathophysiology and a wide range of imaging findings, depending on disease severity and time course. We conducted a retrospective evaluation of hospitalized patients with proven SARS...
Guardado en:
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/dc038b6bd45f49f2a5b2cbfaf0088965 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:dc038b6bd45f49f2a5b2cbfaf0088965 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:dc038b6bd45f49f2a5b2cbfaf00889652021-12-02T11:35:41ZFerritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: data from two Italian COVID-19 units10.1038/s41598-021-83831-82045-2322https://doaj.org/article/dc038b6bd45f49f2a5b2cbfaf00889652021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-83831-8https://doaj.org/toc/2045-2322Abstract The coronavirus 2019 disease (COVID-19) is characterised by a heterogeneous clinical presentation, a complex pathophysiology and a wide range of imaging findings, depending on disease severity and time course. We conducted a retrospective evaluation of hospitalized patients with proven SARS-CoV-2 infection, clinical signs of COVID-19 and computed tomography (CT) scan-proven pulmonary involvement, in order to identify relationships between clinical, serological, imaging data and disease outcomes in patients with COVID-19. Clinical and serological records of patients admitted to two COVID-19 Units of the Abruzzo region in Italy with proven SARS-CoV-2 pulmonary involvement investigated with CT scan, assessed at the time of admission to the hospital, were retrospectively evaluated. Sixty-one patients (22 females and 39 males) of median age 65 years were enrolled. Fifty-six patients were discharged while death occurred in 5 patients. None of the lung abnormalities detected by CT was different between discharged and deceased patients. No differences were observed in the features and extent of pulmonary involvement according to age and gender. Logistic regression analysis with age and gender as covariates demonstrated that ferritin levels over the 25th percentile were associated with the involvement of all 5 pulmonary lobes (OR = 14.5, 95% CI 2.3–90.9, p = 0.004), the presence of septal thickening (OR = 8.2, 95% CI 1.6–40.9, p = 0.011) and the presence of mediastinal lymph node enlargement (OR = 12.0, 95% CI 1.1–127.5, p = 0.039) independently of age and gender. We demonstrated that ferritin levels over the 25th percentile are associated with a more severe pulmonary involvement, independently of age and gender and not associated with disease outcomes. The identification of reliable biomarkers in patients with COVID-19 may help guiding clinical decision, tailoring therapeutic approaches and ultimately improving the care and prognosis of patients with this disease.Francesco CarubbiLia SalvatiAlessia AlunnoFabio MaggiErika BorghiRinalda MarianiFrancesca MaiMaurizio PaoloniClaudio FerriGiovambattista DesideriSabrina CicognaDavide GrassiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Francesco Carubbi Lia Salvati Alessia Alunno Fabio Maggi Erika Borghi Rinalda Mariani Francesca Mai Maurizio Paoloni Claudio Ferri Giovambattista Desideri Sabrina Cicogna Davide Grassi Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: data from two Italian COVID-19 units |
| description |
Abstract The coronavirus 2019 disease (COVID-19) is characterised by a heterogeneous clinical presentation, a complex pathophysiology and a wide range of imaging findings, depending on disease severity and time course. We conducted a retrospective evaluation of hospitalized patients with proven SARS-CoV-2 infection, clinical signs of COVID-19 and computed tomography (CT) scan-proven pulmonary involvement, in order to identify relationships between clinical, serological, imaging data and disease outcomes in patients with COVID-19. Clinical and serological records of patients admitted to two COVID-19 Units of the Abruzzo region in Italy with proven SARS-CoV-2 pulmonary involvement investigated with CT scan, assessed at the time of admission to the hospital, were retrospectively evaluated. Sixty-one patients (22 females and 39 males) of median age 65 years were enrolled. Fifty-six patients were discharged while death occurred in 5 patients. None of the lung abnormalities detected by CT was different between discharged and deceased patients. No differences were observed in the features and extent of pulmonary involvement according to age and gender. Logistic regression analysis with age and gender as covariates demonstrated that ferritin levels over the 25th percentile were associated with the involvement of all 5 pulmonary lobes (OR = 14.5, 95% CI 2.3–90.9, p = 0.004), the presence of septal thickening (OR = 8.2, 95% CI 1.6–40.9, p = 0.011) and the presence of mediastinal lymph node enlargement (OR = 12.0, 95% CI 1.1–127.5, p = 0.039) independently of age and gender. We demonstrated that ferritin levels over the 25th percentile are associated with a more severe pulmonary involvement, independently of age and gender and not associated with disease outcomes. The identification of reliable biomarkers in patients with COVID-19 may help guiding clinical decision, tailoring therapeutic approaches and ultimately improving the care and prognosis of patients with this disease. |
| format |
article |
| author |
Francesco Carubbi Lia Salvati Alessia Alunno Fabio Maggi Erika Borghi Rinalda Mariani Francesca Mai Maurizio Paoloni Claudio Ferri Giovambattista Desideri Sabrina Cicogna Davide Grassi |
| author_facet |
Francesco Carubbi Lia Salvati Alessia Alunno Fabio Maggi Erika Borghi Rinalda Mariani Francesca Mai Maurizio Paoloni Claudio Ferri Giovambattista Desideri Sabrina Cicogna Davide Grassi |
| author_sort |
Francesco Carubbi |
| title |
Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: data from two Italian COVID-19 units |
| title_short |
Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: data from two Italian COVID-19 units |
| title_full |
Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: data from two Italian COVID-19 units |
| title_fullStr |
Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: data from two Italian COVID-19 units |
| title_full_unstemmed |
Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: data from two Italian COVID-19 units |
| title_sort |
ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with covid-19: data from two italian covid-19 units |
| publisher |
Nature Portfolio |
| publishDate |
2021 |
| url |
https://doaj.org/article/dc038b6bd45f49f2a5b2cbfaf0088965 |
| work_keys_str_mv |
AT francescocarubbi ferritinisassociatedwiththeseverityoflunginvolvementbutnotwithworseprognosisinpatientswithcovid19datafromtwoitaliancovid19units AT liasalvati ferritinisassociatedwiththeseverityoflunginvolvementbutnotwithworseprognosisinpatientswithcovid19datafromtwoitaliancovid19units AT alessiaalunno ferritinisassociatedwiththeseverityoflunginvolvementbutnotwithworseprognosisinpatientswithcovid19datafromtwoitaliancovid19units AT fabiomaggi ferritinisassociatedwiththeseverityoflunginvolvementbutnotwithworseprognosisinpatientswithcovid19datafromtwoitaliancovid19units AT erikaborghi ferritinisassociatedwiththeseverityoflunginvolvementbutnotwithworseprognosisinpatientswithcovid19datafromtwoitaliancovid19units AT rinaldamariani ferritinisassociatedwiththeseverityoflunginvolvementbutnotwithworseprognosisinpatientswithcovid19datafromtwoitaliancovid19units AT francescamai ferritinisassociatedwiththeseverityoflunginvolvementbutnotwithworseprognosisinpatientswithcovid19datafromtwoitaliancovid19units AT mauriziopaoloni ferritinisassociatedwiththeseverityoflunginvolvementbutnotwithworseprognosisinpatientswithcovid19datafromtwoitaliancovid19units AT claudioferri ferritinisassociatedwiththeseverityoflunginvolvementbutnotwithworseprognosisinpatientswithcovid19datafromtwoitaliancovid19units AT giovambattistadesideri ferritinisassociatedwiththeseverityoflunginvolvementbutnotwithworseprognosisinpatientswithcovid19datafromtwoitaliancovid19units AT sabrinacicogna ferritinisassociatedwiththeseverityoflunginvolvementbutnotwithworseprognosisinpatientswithcovid19datafromtwoitaliancovid19units AT davidegrassi ferritinisassociatedwiththeseverityoflunginvolvementbutnotwithworseprognosisinpatientswithcovid19datafromtwoitaliancovid19units |
| _version_ |
1718395851306434560 |